Aptevo Therapeutics announces exercise of existing warrants for $3M gross proceeds (APVO:NASDAQ)November 11, 2026
Share Facebook Twitter LinkedIn Pinterest Email CoreWeave CEO says he's cancelled his 10b5-1 plan – CNBC
Aptevo Therapeutics announces exercise of existing warrants for $3M gross proceeds (APVO:NASDAQ)November 11, 2026